Li CJ - Search Results

1

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.

Li CJ, Yu Q, Yu P, Yu TL, Zhang QM, Lu S, Yu DM. Li CJ, et al. Cardiovasc Diabetol. 2014 Feb 5;13:36. doi: 10.1186/1475-2840-13-36. Cardiovasc Diabetol. 2014. PMID: 24498905 Free PMC article.

2

Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.

Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P, Yu DM. Li CJ, et al. Among authors: li mz. Chin Med J (Engl). 2009 Nov 5;122(21):2580-6. Chin Med J (Engl). 2009. PMID: 19951573

3

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.

Li CJ, Lv L, Li H, Yu DM. Li CJ, et al. Among authors: li h. Cardiovasc Diabetol. 2012 Jun 19;11:73. doi: 10.1186/1475-2840-11-73. Cardiovasc Diabetol. 2012. PMID: 22713251 Free PMC article.

4

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.

Li CJ, Li J, Zhang QM, Lv L, Chen R, Lv CF, Yu P, Yu DM. Li CJ, et al. Among authors: li j. Cardiovasc Diabetol. 2012 Nov 15;11:142. doi: 10.1186/1475-2840-11-142. Cardiovasc Diabetol. 2012. PMID: 23153177 Free PMC article. Clinical Trial.

5

Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke.

Li CJ, Liu Y, Chen Y, Yu D, Williams KJ, Liu ML. Li CJ, et al. Am J Pathol. 2013 May;182(5):1552-62. doi: 10.1016/j.ajpath.2013.01.035. Epub 2013 Mar 13. Am J Pathol. 2013. PMID: 23499464 Free PMC article.

6

C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway.

Zhang R, Zhou SJ, Li CJ, Wang XN, Tang YZ, Chen R, Lv L, Zhao Q, Xing QL, Yu DM, Yu P. Zhang R, et al. Among authors: li cj. Lipids Health Dis. 2013 Mar 26;12:42. doi: 10.1186/1476-511X-12-42. Lipids Health Dis. 2013. PMID: 23531147 Free PMC article.

7

Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis.

Wang WL, Meng ZX, Zhou SJ, Li CJ, Chen R, Lv L, Ma ZJ, Yu DM, Yu P. Wang WL, et al. Among authors: li cj. Lipids Health Dis. 2013 Nov 16;12:174. doi: 10.1186/1476-511X-12-174. Lipids Health Dis. 2013. PMID: 24238298 Free PMC article.

8

Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes.

Li CJ, Zhang JY, Yu DM, Zhang QM. Li CJ, et al. Diabetol Metab Syndr. 2014 Mar 20;6(1):41. doi: 10.1186/1758-5996-6-41. Diabetol Metab Syndr. 2014. PMID: 24650537 Free PMC article.

9

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents.

Li CJ, Liu XJ, Bai L, Yu Q, Zhang QM, Yu P, Yu DM. Li CJ, et al. Diabetol Metab Syndr. 2014 May 31;6:69. doi: 10.1186/1758-5996-6-69. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 24917890 Free PMC article.

10

Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.

Zhou SJ, Bai L, Lv L, Chen R, Li CJ, Liu XY, Yu DM, Yu P. Zhou SJ, et al. Among authors: li cj. Mol Med Rep. 2014 Nov;10(5):2587-94. doi: 10.3892/mmr.2014.2555. Epub 2014 Sep 10. Mol Med Rep. 2014. PMID: 25215431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,567 results

Search Page

Filters